| 摘要: |
| 目的 辅料在改善鼻用粉雾剂递送性能方面具有关键作用,本研究拟构建用于体外鼻腔递送性能的表征方法,并考察辅料种类及制备过程工艺参数对左旋多巴微粒结构的影响规律,及其与体外鼻腔释放和粘附性能间的关联关系。方法 通过微流控喷雾冷冻干燥技术,选择不同辅料制备了一系列左旋多巴微粒,采用改进的Franz扩散池和自主搭建的多通道微粒粘附性能测量装置分别评价了微粒的体外鼻腔释放和粘附性能。结果 喷雾冷冻干燥左旋多巴微粒均为多孔的球型,且辅料分子量较高的样品表面会形成一层均匀的薄膜。多孔结构主导了左旋多巴微粒的体外释放行为,配方为L1M4的样品体外释放性能最佳,其在60 min时累计释放率可达86.57%。受到辅料亲水性及微粒表面薄膜结构的影响,体外粘附性能最佳的样品为L1C4,10 min时其在琼脂表面的滞留量约为61.75%。结论 本研究阐明了辅料种类与微粒结构对左旋多巴微粒体外鼻腔释放和粘附性能的交叉影响规律,并据此提出了可增强体外鼻腔释放和粘附性能所对应的配方和制备工艺参数。 |
| 关键词: 左旋多巴 鼻腔给药 喷雾冷冻干燥 体外鼻腔释放性能 体外鼻腔黏附性能 |
| DOI:10.13506/j.cnki.jpr.2025.05.003 |
| 基金项目:国家自然科学基金面上项目(No.22278284) |
|
Publication Date:May 25, 2025
|
|
| The effect of different excipients on the nasal delivery performance of levodopa microparticles |
| XIE Shuaiyu,LI Mengyuan,YAN Shen,ZHANG Shengyu,WU Duo |
| (College of Chemistry, Chemical Engineering and Materials Science of Soochow University, Suzhou 215123,China) |
| Abstract: |
| Objective Excipients play a crucial role in enhancing the delivery performance of nasal powders. This study aims to estabilsh an in vitro evaluation method for nasal delivery performance to investigate the effects of excipients and process parameters on the structure of levodopa microparticles, as well as their correlation with in vitro nasal release and adhesion performance. Methods Levodopa microparticles were fabricated via a self-designed micro-fluidic jet spray freeze drying technology with different excipients. The in vitro nasal release and adhesion properties of the microparticles were evaluated using a modified Franz diffusion cell and a self-designed multi-channel microparticles adhesion property measurement device. Results The spray freeze dried samples showed spherical and porous morphology, and samples containing higher molecular weight excipients formed a film on their surfaces. The porous structure of the microparticles dominated their in vitro release profils, with the best release performance achieved by formulation L1M4, reaching a cumulative release rate of ~ 86.57% at 60 minutes. The in vitro adhesion performance was best for formulation L1C4, with a surface retention of about 61.75% at 10 minutes, influenced by the hydrophilicity of the microparticles and their surface film structure. Conclusion This study elucidates the cross-influence of excipient types and microparticle structure on the in vitro nasal release and adhesion properties of levodopa microparticles and proposes corresponding formulations and process parameters to enhance these performances. |
| Key words: Levodopa Nasal Administration Spray Freeze Drying In Vitro Nasal Release Performance In Vitro Nasal Adhesion Performance |